Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin.
Saved in:
| Title: | Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin. |
|---|---|
| Authors: | Newbold A; Cancer Immunology Program, Peter MacCallum Cancer Centre, Trescowthick Research Laboratories, St. Andrews Place, East Melbourne, Victoria 3002, Australia., Lindemann RK, Cluse LA, Whitecross KF, Dear AE, Johnstone RW |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2008 May; Vol. 7 (5), pp. 1066-79. |
| Publication Type: | Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Print ISSN: 1535-7163 (Print) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 18483296 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Newbold+A%22">Newbold A</searchLink>; Cancer Immunology Program, Peter MacCallum Cancer Centre, Trescowthick Research Laboratories, St. Andrews Place, East Melbourne, Victoria 3002, Australia.<br /><searchLink fieldCode="AU" term="%22Lindemann+RK%22">Lindemann RK</searchLink><br /><searchLink fieldCode="AU" term="%22Cluse+LA%22">Cluse LA</searchLink><br /><searchLink fieldCode="AU" term="%22Whitecross+KF%22">Whitecross KF</searchLink><br /><searchLink fieldCode="AU" term="%22Dear+AE%22">Dear AE</searchLink><br /><searchLink fieldCode="AU" term="%22Johnstone+RW%22">Johnstone RW</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2008 May; Vol. 7 (5), pp. 1066-79. – Name: TypePub Label: Publication Type Group: TypPub Data: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>1535-7163 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=18483296 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1535-7163.MCT-07-2256 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1066 Titles: – TitleFull: Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Newbold A – PersonEntity: Name: NameFull: Lindemann RK – PersonEntity: Name: NameFull: Cluse LA – PersonEntity: Name: NameFull: Whitecross KF – PersonEntity: Name: NameFull: Dear AE – PersonEntity: Name: NameFull: Johnstone RW IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2008 May Type: published Y: 2008 Identifiers: – Type: issn-print Value: 1535-7163 Numbering: – Type: volume Value: 7 – Type: issue Value: 5 Titles: – TitleFull: Molecular cancer therapeutics Type: main |
| ResultId | 1 |
